Compayan, Bb Boy -.

HRN: 22-25-65  Sex: Male

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
11/28/2022
PIPERACILLIN + TAZOBACTAM 2.25G (VIAL)
11/28/2022
12/05/2022
IVT
338 Mg
6 Hrs
PCAP D
Waiting Final Action 
11/28/2022
CEFTRIAXONE 1G (VIAL)
11/28/2022
12/05/2022
IV
450 Mg
Q24
PCAP D
Waiting Final Action 
11/28/2022
AMIKACIN 250MG/ML, 2ML (VIAL/AMP)
11/28/2022
12/05/2022
IV
65 Mg
Q24
PCAP D
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: